Presentation is loading. Please wait.

Presentation is loading. Please wait.

Current vs. future Current system Products are risk assessed, looking at all the risks. Products authorised only if these risks are considered acceptable.

Similar presentations


Presentation on theme: "Current vs. future Current system Products are risk assessed, looking at all the risks. Products authorised only if these risks are considered acceptable."— Presentation transcript:

1 Current vs. future Current system Products are risk assessed, looking at all the risks. Products authorised only if these risks are considered acceptable.  A sensible system that has worked well for many years! Commission Proposal: Substances will be banned when they have particular properties – even if the associated risk is very low!! European Parliament Plenary Vote: More extreme position – meaning the loss of many safe products!!

2 Many active substances already lost since the early ‘90’s And the impact of losing two thirds of what is left??? What impact...? 0 200 400 600 800 1000 199319951997199920012003200520072009 Year Number New Compounds Existing Compounds Source: European Commission

3 What impact...? Insecticides –% substances that would be lost if: Parliament proposal – would be a ban on: All pyrethroids, All organophosphates All carbamates Most neonicitinoides COMMISSION % ASs 8%Minimum 20%Maximum PARLIAMENT % ASs 83%Minimum 94%Maximum

4 What impact...? Fungicides – % substances that would be lost if: Parliament proposal – would be a ban on: All triazoles All dithiocarbamates A number of Strobulorins COMMISSION % ASs 12%Minimum 34%Maximum PARLIAMENT % ASs 69%Minimum 85%Maximum

5 What impact...? Herbicides – % substances that would be lost if: Parliament proposal – would be a ban on: All dinitroanalines All pyridines And ‘FOPs’ would be at risk COMMISSION % ASs 10%Minimum 23%Maximum PARLIAMENT % ASs 55%Minimum 81%Maximum

6 Cut offs proposed – More detail! Commission Proposal: Substances will be banned when they have particular properties Endocrine disruptors CMR-1/2 - Substances that may have carcinogenic (C), mutagenic (M) or reprotoxic (R) characteristics Note: Alcohol is an endocrine disruptor, as well as being a C, an M and an R POPs (Persistent Organic Pollutants) – trigger criteria set out for Persistency, Bio- accumulation and potential for long-range transport PBT – trigger criteria for Persistency, Bio-accumulation and Toxicity vPvB - trigger criteria for very Persistent and very Bio-accumulative European Parliament Plenary Vote: More extreme position – meaning the loss of many safe products!! Trigger only 1 of the 4 POPs criteria (Persistent Organic Pollutants) – see above This criteria alone would mean the loss of over half of our substances Developmental Neurotoxic immunotoxicity, bee toxicity... The Parliament criteria would have the biggest impact on insecticides!

7 210 substances evaluated: 3% (poss.7%) trigger CMR 1&2 (‘R’ up to 6%) 15% (poss.20%) trigger neurotoxicity (developmental?) <1% trigger immunotoxicity 55% (poss.70%) trigger 1 out of 4 POP criteria (‘T’ approx 50%); <1% trigger all 4 criteria (Comm proposal) <1% trigger PBT & vPvB 3% (poss.20%) trigger endocrine disruption (human & env.) 15% (poss.20%) trigger toxicity to bees criteria (HQ>50) More detailed information Results of survey – each criteria

8 Endocrine disruptors (DHI report for EU Commission, May 2007) Category 1Category 2 A.s. nameAnnex IA.s. nameAnnex I MetiramYesCypermethrinYes ProcymidoneYesBromoxynilYes MancozebYesIprodioneYes FenarimolYesDimethoateYes DeltamethrinYesCarbendazimYes MetribuzinYesZiramYes Lambda cyhalothrinYesFluvalinate (tau-fluvalinate?)Pending IoxynilYesFenoxycarbPending LinuronYesEtridiazolePending ThiramYesTriadimenolPending Amitrole (aminotriazole)YesPyrethrin (organagri)Pending ManebYesDicofolPending PicloramPendingProchlorazPending BifenthrinPendingMethylbromidePending Metam sodiumPendingPropanilPending AcetochlorPendingPiperonyl butoxide (synergist)Not an a.s.

9 Endocrine disruptors A.s. nameAnnex I MetiramYes ProcymidoneYes MancozebYes FenarimolYes DeltamethrinYes MetribuzinYes Lambda cyhalothrinYes IoxynilYes LinuronYes ThiramYes Amitrole (aminotriazole)Yes ManebYes PicloramPending BifenthrinPending Metam sodiumPending AcetochlorPending


Download ppt "Current vs. future Current system Products are risk assessed, looking at all the risks. Products authorised only if these risks are considered acceptable."

Similar presentations


Ads by Google